- call +1-201-465-4211
- email sales@mrinsights.biz
Inflammatory bowel disease (IBD) is a broad term used to describe disorders involving chronic inflammation of digestive tract. The disease is categorized by severe diarrhea, abdominal pain, fatigue, and weight loss.
Scope of the Report:
Increase in incidences of IBD and rise in adoption of anti-inflammatory drugs drive the market.
In addition, strong upcoming pipeline of IBD drugs also boosts the market growth.
However, side effects of these drugs over a patients body restrain the market growth.
The worldwide market for Inflammatory Bowel Disease Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Inflammatory Bowel Disease Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Abbvie
Johnson & Johnson
GlaxoSmithKline
Merck
Novartis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory drugs (NSAIDs)
Corticosteroids
Market Segment by Applications, can be divided into
Solid
Liquid
There are 15 Chapters to deeply display the global Inflammatory Bowel Disease Therapeutics market.
Chapter 1, to describe Inflammatory Bowel Disease Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Inflammatory Bowel Disease Therapeutics, with sales, revenue, and price of Inflammatory Bowel Disease Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Inflammatory Bowel Disease Therapeutics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Inflammatory Bowel Disease Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Inflammatory Bowel Disease Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Inflammatory Bowel Disease Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Anti-inflammatory Biologics
1.2.2 Non-Steroidal Anti-inflammatory drugs (NSAIDs)
1.2.3 Corticosteroids
1.3 Market Analysis by Applications
1.3.1 Solid
1.3.2 Liquid
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbvie
2.1.1 Business Overview
2.1.2 Inflammatory Bowel Disease Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbvie Inflammatory Bowel Disease Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Inflammatory Bowel Disease Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Inflammatory Bowel Disease Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Inflammatory Bowel Disease Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Inflammatory Bowel Disease Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Inflammatory Bowel Disease Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Inflammatory Bowel Disease Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Inflammatory Bowel Disease Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Inflammatory Bowel Disease Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Inflammatory Bowel Disease Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Inflammatory Bowel Disease Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Inflammatory Bowel Disease Therapeutics Manufacturer Market Share in 2017
3.3.2 Top 6 Inflammatory Bowel Disease Therapeutics Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Inflammatory Bowel Disease Therapeutics Market Analysis by Regions
4.1 Global Inflammatory Bowel Disease Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Inflammatory Bowel Disease Therapeutics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Inflammatory Bowel Disease Therapeutics Revenue and Market Share by Regions (2013-2018)
4.2 North America Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
4.3 Europe Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
4.5 South America Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
5 North America Inflammatory Bowel Disease Therapeutics by Countries
5.1 North America Inflammatory Bowel Disease Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America Inflammatory Bowel Disease Therapeutics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Inflammatory Bowel Disease Therapeutics Revenue and Market Share by Countries (2013-2018)
5.2 United States Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
5.3 Canada Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
5.4 Mexico Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
6 Europe Inflammatory Bowel Disease Therapeutics by Countries
6.1 Europe Inflammatory Bowel Disease Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe Inflammatory Bowel Disease Therapeutics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Inflammatory Bowel Disease Therapeutics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
6.3 UK Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
6.4 France Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
6.5 Russia Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
6.6 Italy Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Inflammatory Bowel Disease Therapeutics by Countries
7.1 Asia-Pacific Inflammatory Bowel Disease Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Inflammatory Bowel Disease Therapeutics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Inflammatory Bowel Disease Therapeutics Revenue and Market Share by Countries (2013-2018)
7.2 China Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
7.3 Japan Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
7.4 Korea Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
7.5 India Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
8 South America Inflammatory Bowel Disease Therapeutics by Countries
8.1 South America Inflammatory Bowel Disease Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Inflammatory Bowel Disease Therapeutics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Inflammatory Bowel Disease Therapeutics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
8.3 Argentina Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
8.4 Colombia Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Inflammatory Bowel Disease Therapeutics by Countries
9.1 Middle East and Africa Inflammatory Bowel Disease Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Inflammatory Bowel Disease Therapeutics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Inflammatory Bowel Disease Therapeutics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
9.3 UAE Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
9.4 Egypt Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
9.5 Nigeria Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
9.6 South Africa Inflammatory Bowel Disease Therapeutics Sales and Growth Rate (2013-2018)
10 Global Inflammatory Bowel Disease Therapeutics Market Segment by Type
10.1 Global Inflammatory Bowel Disease Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Inflammatory Bowel Disease Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global Inflammatory Bowel Disease Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Anti-inflammatory Biologics Sales Growth and Price
10.2.1 Global Anti-inflammatory Biologics Sales Growth (2013-2018)
10.2.2 Global Anti-inflammatory Biologics Price (2013-2018)
10.3 Non-Steroidal Anti-inflammatory drugs (NSAIDs) Sales Growth and Price
10.3.1 Global Non-Steroidal Anti-inflammatory drugs (NSAIDs) Sales Growth (2013-2018)
10.3.2 Global Non-Steroidal Anti-inflammatory drugs (NSAIDs) Price (2013-2018)
10.4 Corticosteroids Sales Growth and Price
10.4.1 Global Corticosteroids Sales Growth (2013-2018)
10.4.2 Global Corticosteroids Price (2013-2018)
11 Global Inflammatory Bowel Disease Therapeutics Market Segment by Application
11.1 Global Inflammatory Bowel Disease Therapeutics Sales Market Share by Application (2013-2018)
11.2 Solid Sales Growth (2013-2018)
11.3 Liquid Sales Growth (2013-2018)
12 Inflammatory Bowel Disease Therapeutics Market Forecast (2018-2023)
12.1 Global Inflammatory Bowel Disease Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Inflammatory Bowel Disease Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America Inflammatory Bowel Disease Therapeutics Market Forecast (2018-2023)
12.2.2 Europe Inflammatory Bowel Disease Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Inflammatory Bowel Disease Therapeutics Market Forecast (2018-2023)
12.2.4 South America Inflammatory Bowel Disease Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Inflammatory Bowel Disease Therapeutics Market Forecast (2018-2023)
12.3 Inflammatory Bowel Disease Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global Inflammatory Bowel Disease Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global Inflammatory Bowel Disease Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Inflammatory Bowel Disease Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global Inflammatory Bowel Disease Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global Inflammatory Bowel Disease Therapeutics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Inflammatory Bowel Disease Therapeutics Picture
Table Product Specifications of Inflammatory Bowel Disease Therapeutics
Figure Global Sales Market Share of Inflammat
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
